Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Business & Industry
- Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
- Bayer Consumer Health leaders propose new principles for science-led self-care
- GSK signs agreement to support pandemic preparedness in Europe
- Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
- AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager
Research & Development
- Treating cancer by sticking cells in place
- Vitamin K prevents cell death: a new function for a long-known molecule
- Disparities in United States COVID-19 vaccine distribution
- New needle-free nasal vaccine shows promise for COVID-19
- Scientists develop new biomimetic formulation for treating glioblastoma
- SARS-CoV-2 hijacks nanotubes between neurons to infect them
- Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
Conferences & Events
- New approach to treatment of deadly kidney cancer
- SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
- Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
- SMi's 22nd Annual Pain Therapeutics Conference
- SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
- SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
- SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals
- EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- FDA approves first generic of Symbicort to treat asthma and COPD